Male Androgenetic Alopecia

The 2014 study "Male androgenetic alopecia" discussed Androgenetic Alopecia (AGA), a common form of hair loss linked to age, genetic factors, and androgens. The disease was observed in the temporal and vertex areas postpuberty, with a decrease in the anagen/telogen ratio. Treatments included topical minoxidil, oral finasteride, and surgical methods. The study found that 15% of male participants experienced new hair growth with minoxidil, 50% had delayed hair loss, and 35% continued to lose hair. A 5% minoxidil solution was more effective than a 2% solution. However, hair loss resumed once treatment stopped. Daily use of 1 mg finasterid resulted in hair increase in 48% of participants by the end of the first year and 66% by the end of the second year. The study also noted that AGA could be an indicator of early-onset coronary diseases, hyperinsulinemia, insulin resistance, and obesity. Future treatments under research included second-generation steroidal 5-alpha inhibitors. The number of participants was not specified.